NLRP3 and early-onset autosomal dominant Alzheimer disease: Therefore, it has been proposed that this NLRP3 beneficial function in homeostasis could become harmful during the onset of inflammatory and metabolic diseases, such as multiple sclerosis or Alzheimer’s disease.